AB
CINC

Amalgamated Bank’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Amalgamated Bank’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,111
Closed -$38K – 2962
2022
Q4 		$38K Buy
3,111
+441
+17% +$10.5K ﹤0.01% 2547
2022
Q3 		$88K Buy
2,670
+567
+27% +$16K ﹤0.01% 2210
2022
Q2 		$40K Sell
2,103
-168
-7% -$3.22K ﹤0.01% 2595
2022
Q1 		$40K Buy
+2,271
New +$46.6K ﹤0.01% 2582

Amalgamated Bank's CINC Position: Q1 2023 in Review

Amalgamated Bank sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 3,111 shares — an estimated $38K sold.

Amalgamated Bank first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $88K in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Amalgamated Bank reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Amalgamated Bank sold 3,111 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $38K.
  • Amalgamated Bank first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • Amalgamated Bank's CinCor Pharma, Inc. Common Stock position peaked at $88K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Amalgamated Bank's 13F filing for Q1 2023, filed 2 May 2023.